See also this year's filing and all EDGAR filings for this company.
PDF Report 0000818686_2022_TEVA_PHARMACEUTICAL_INDUSTRIES_LTD.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 2.0978874273606477e-05, 'aggregate_val': 47666000000, 'exp_sum': 47667000000, 'exp_to_value': {'AssetsCurrent': 12573000000, 'IntangibleAssetsNetIncludingGoodwill': 27506000000, 'PropertyPlantAndEquipmentNet': 5982000000, 'remainder_Assets': 1606000000}} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000818686, TEVA PHARMACEUTICAL INDUSTRIES LTD
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 12,573,000,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 27,506,000,000 |
| 2 | PropertyPlantAndEquipmentNet | 5,982,000,000 |
| 3 | remainder_Assets | 1,605,000,000 |
| 4 | LiabilitiesCurrent | 11,027,000,000 |
| 5 | LiabilitiesNoncurrent | 25,395,000,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 8,284,000,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,099,000,000 |
| 9 | ResearchAndDevelopmentExpense | 967,000,000 |
| 10 | remainder_Expenses | 4,122,000,000 |
| 11 | remainder_Revenues | 15,878,000,000 |
| 12 | remainder_NetIncome | -951,000,000 |
| 13 | remainder_ComprehensiveNetIncome | -323,000,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 47,666,000,000 |
| 1 | Liabilities | 36,422,000,000 |
| 2 | Expenses | 14,472,000,000 |
| 3 | Revenues | 15,878,000,000 |
| 4 | StockholdersEquity | 11,244,000,000 |
| 5 | NetIncome | 455,000,000 |
| 6 | ComprehensiveNetIncome | 293,500,000 |
| 7 | BaseVar | 57,856,000,000 |
| 8 | EconomicCapitalRatio | 0.467 |
Edgar->Model Mapping
Feature Distribution
Change over Time
